Total Funding
27
55
Total FundingPost-IPO Equity raised
Growth Score
1 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
144237
PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets.
- Lenard M. Lichtenberger: Scientific Founder
- Robert W. Strozier: Outside Patent Counsel
About the Company
PLx Pharma is a pharmaceutical company that develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine; and PL1100/1200 Ibuprofen, which are oral drug products containing
a molecular complex of ibuprofen and phosphatidylcholine.
Women Led
